Tower Research Capital (TRC)’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.66K | Buy |
4,098
+1,543
| +60% | +$2.89K | ﹤0.01% | 4044 |
|
|
2025
Q1 | $4.55K | Buy |
2,555
+2,141
| +517% | +$3.81K | ﹤0.01% | 4240 |
|
|
2024
Q4 | $1.31K | Sell |
414
-1,379
| -77% | -$4.35K | ﹤0.01% | 5049 |
|
|
2024
Q3 | $3.69K | Sell |
1,793
-11,875
| -87% | -$24.5K | ﹤0.01% | 4795 |
|
|
2024
Q2 | $20K | Buy |
13,668
+10,169
| +291% | +$14.8K | ﹤0.01% | 3766 |
|
|
2024
Q1 | $8.19K | Sell |
3,499
-1,772
| -34% | -$4.15K | ﹤0.01% | 4065 |
|
|
2023
Q4 | $10.6K | Sell |
5,271
-11,330
| -68% | -$22.9K | ﹤0.01% | 4220 |
|
|
2023
Q3 | $80.3K | Buy |
16,601
+15,081
| +992% | +$73K | ﹤0.01% | 2148 |
|
|
2023
Q2 | $10.4K | Buy |
1,520
+392
| +35% | +$2.68K | ﹤0.01% | 4103 |
|
|
2023
Q1 | $8K | Sell |
1,128
-3,488
| -76% | -$24.7K | ﹤0.01% | 4683 |
|
|
2022
Q4 | $60K | Sell |
4,616
-1,846
| -29% | -$24K | ﹤0.01% | 2214 |
|
|
2022
Q3 | $91K | Buy |
6,462
+2,408
| +59% | +$33.9K | ﹤0.01% | 2648 |
|
|
2022
Q2 | $50K | Buy |
4,054
+2,607
| +180% | +$32.2K | ﹤0.01% | 2887 |
|
|
2022
Q1 | $25K | Buy |
1,447
+1,277
| +751% | +$22.1K | ﹤0.01% | 3341 |
|
|
2021
Q4 | $4K | Buy |
170
+130
| +325% | +$3.06K | ﹤0.01% | 5355 |
|
|
2021
Q3 | $1K | Buy |
+40
| New | +$1K | ﹤0.01% | 5557 |
|
|
2021
Q2 | – | Sell |
-219
| Closed | -$4K | – | 5919 |
|
|
2021
Q1 | $4K | Sell |
219
-8
| -4% | -$146 | ﹤0.01% | 4819 |
|
|
2020
Q4 | $3K | Buy |
227
+46
| +25% | +$608 | ﹤0.01% | 4837 |
|
|
2020
Q3 | $4K | Sell |
181
-833
| -82% | -$18.4K | ﹤0.01% | 4449 |
|
|
2020
Q2 | $19K | Buy |
+1,014
| New | +$19K | ﹤0.01% | 3714 |
|
|
2019
Q1 | – | Sell |
-274
| Closed | -$7K | – | 4365 |
|
|
2018
Q4 | $7K | Buy |
+274
| New | +$7K | ﹤0.01% | 2727 |
|
|
2018
Q3 | – | Sell |
-7
| Closed | – | – | 4320 |
|
|
2018
Q2 | $0 | Buy |
+7
| New | – | ﹤0.01% | 4135 |
|